Deji Adegunsoye, MD, PhD

Physician, Dad, Professor of Medicine @UChicagoMed| Intensivist |Pulmonologist🫁|Geneticist🧬| Fighting #PulmonaryFibrosis |Opinions=mine only

[Deji Adegunsoye, MD, PhD @drdayjee]

🔥🔥🔥Excited to share our latest review in AJRCCM delving into intricate genetic & epigenetic frameworks shaping #pulmonaryfibrosis & unraveling its complexities.

Grateful for collaboration with @JKropski @AnnaPodolanczuk @jskim8223, & all contributors.

https://t.co/FuOQHnn7t5

[Deji Adegunsoye, MD, PhD @drdayjee]

Deeply honored to contribute to the August 15 issue of The Blue Journal.

My heartfelt thanks to the incredible team who enabled this.

Together we continue to push the boundaries of knowledge in inflammation, fibrosis, genetics, & machine learning.

Onward!

#Grateful #Research

[Naftali Kaminski @KaminskiMed]

"The End of Rarity" is important. Reflects something we all felt, that if we improved IPF survival it will quickly cease to be a rare disease. But mortality is way too high. 👋🏼👋🏼 Drs Massen, Nvaratnan & team.
#MustRead
#RareNoMore
#CurePF4All
https://t.co/1vTrJjmO9d

[Naftali Kaminski @KaminskiMed]

The first snRNASeq & spatial transcriptomic analysis of bronchoscopic cryobiopsies from patients with Early IPF & preserved pulmonary functions is out on @biorxivpreprint and message is Early IPF is IPF‼️
https://t.co/yyX28bn7D2

[David Zhang @DavidZhangMD]

Genetic heterogeneity in IPF has been a major gap. In our new paper, we define genetic endotypes of IPF, uncover subtype-specific risk, improve disease prediction, and identify telomere-associated polygenic risk as a key, previously unrecognized driver.

https://t.co/EoBzewQO0t

[Naftali Kaminski @KaminskiMed]

Finally in Print! The Official ATS Research Statement on Racial, Ethnic, Sex & Gender Equity for Inclusive Interstitial Lung Disease Research.
👏🏼 Drs Assayag, Adegonsoye, Cottin, Mageto, @ATSBlueEditor & the subcommittee members!!
#CurePF4All
https://t.co/rjA5BxVoDb

[CME Outfitters @cmeoutfitters]

Overheard at #ECPPILD2025 today in Orlando: ""The prevalence of ILD is increasing and may be even higher than estimated because of failure to recognize the disease in clinical practice. We have the tools to better manage ILD, but recognition is key!" - @drdayjee Deji Adegunsoye, MD @PFWarrior @MartinezFerMD @joycecylee @scott_matson @AnnaPodolanczuk @OneVoiceILD @Pfforg #MedEd #MedTwitter #ILD

[ERS @EuroRespSoc]

Dr Ayodeji Adegunsoye – statement Co-Chair – gives a brief overview on the new Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement 📽️ 📖

Watch now on our ERS LinkedIn channel: https://t.co/MLkwW30E0f

[CME Outfitters @cmeoutfitters]

Deji Adegunsoye, MD, MSc, PhD, FCCP (@drdayjee) brings expertise as Scientific Director of the ILD Program at @UChicagoMed to the 2025 Early Career Preceptorship Program on ILD!

Join him for insights on multidisciplinary approaches to optimizing patient care.

🔗 https://t.co/STOZtwsRbV

#ILD #Pulmonology #LungHealth #MedEd #PulmonaryCare

[John Kim @jskim8223]

Excited to share our study that is online @ThoraxBMJ examining clinical trajectories by ILD subtype and CT UIP pattern

https://t.co/8flG2CcH7f

[Naftali Kaminski @KaminskiMed]

Our newest paper: “Predicting lung aging using using single cell RNASeq data״ see thread below 👇🏼
https://t.co/h0WbkuD4qF

[Yoav Gilad @Y_Gilad]

My book, An Intuitive Primer on Effective Functional Genomics Study Design, is published! I’d really appreciate it if you could help spread the word, and I’d love to hear your thoughts and feedback. It’s available on Amazon: https://t.co/VKR3l4RTSA

[Deji Adegunsoye, MD, PhD @drdayjee]

@DzekemB @UChicago @Harvard @BrighamWomens @BrighamFellows @UChicagoMed @MedChiefs Congratulations, Bona!!! You’ve earned it!
So proud of you! 🥂🍾

[Naftali Kaminski @KaminskiMed]

Really cool! Our ‘Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis’ is on cover of the American Journal of Respiratory & Critical Care Medicine. Kudos to soon to be #DoubleDoc Amy Zhao & crew!!
#BestStudents
https://t.co/xaxllX5YtZ

[Deji Adegunsoye, MD, PhD @drdayjee]

Truly honored to be the keynote speaker at this incredible event!

I loved every moment in Toronto, meeting such inspiring minds and learning about the amazing work you all are doing in pulmonary fibrosis.

Thank you for the warm welcome and the inspiration!🙏🏽🇨🇦

[Shane Shapera @shapps999]

@jolenehfisher, @twhcmr and I were honored to have @drdayjee at our @UofTRespirology #ILD educational day. He gave a fantastic talk on genetics of ILD and biomarkers: past, present and future. Thanks @drdayjee for coming along the way to Toronto to enhance our event! 🙏🙏🙏

[Rachel Putman @rachelkputman]

Belated ICLAF appreciation post - such a wonderful time with amazing people and great science in a beautiful location! Athens was amazing! #ICLAF2024

[Naftali Kaminski @KaminskiMed]

@drdayjee @KerriBerriKerri @atzouvelekis @PilarRiveraOrt1 @AnnaPodolanczuk @ericafarrandMD @Eickelberg_MD @DrPeter_George @leticiakawano @RealEricJWhite @LouiseVwain @GlassbeMK @JVPugashetti @aravindamenon @MTFreeberg @rachelkputman @glaspoletweet @NaamaAvitzur Truth is - what I love most in Athens & in Greece - the people - their resilience, activism, energy and generosity 🥰

[Deji Adegunsoye, MD, PhD @drdayjee]

@KaminskiMed @KerriBerriKerri @atzouvelekis @PilarRiveraOrt1 @AnnaPodolanczuk @ericafarrandMD @Eickelberg_MD @DrPeter_George @leticiakawano @RealEricJWhite Day or night, the landscape dazzled with magnificent structures and breathtaking views—an awe-inspiring spectacle at every turn!

🏛️

#ICLAF2024

[Deji Adegunsoye, MD, PhD @drdayjee]

Still basking in fun times & learnings from Athens🇬🇷 this week at #ICLAF2024:

• multiomics of pulmonary fibrosis 🫁
• novel pathophysiologic findings 🧬
• potential therapeutic targets 💊
• …and of course, insights into Greek mythology🏛️

#ScienceWin #MedTwitter #CurePF

[Deji Adegunsoye, MD, PhD @drdayjee]

Athens: where medicine, democracy, philosophy, and the Olympics were born!

This ancient city isn’t just a historical wonder—it’s a feast for the eyes, overflowing with culture, charm, and jaw-dropping views.

[Deji Adegunsoye, MD, PhD @drdayjee]

@avishvj @GlassbeMK

[Deji Adegunsoye, MD, PhD @drdayjee]

Dr. Marilyn Glassberg delivers an outstanding talk on sex differences in pulmonary fibrosis.
• need early disease models
• being female appears to be protective.
• Nitrogen mustard model is quite similar to Bleo
• Estrogen did not seem to stimulate fibrosis

#ICLAF2024

[CFlores-Lab @LabCflores]

Delighted to share our new study led by @AitanaAG90 evaluating the association of rare variants in telomere and non-telomere monogenic adult-onset Pulmonary Fibrosis genes and IPF patient survival where we also intersected their effects with #PRS of IPF. https://t.co/UbYc8SO8zT